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osting by EAbstract Background: The introduction of technique of radiofrequency (RF) catheter ablation in
1990, has revolutionized management of different types of paroxysmal supraventricular tachycardia
(PSVT). In spite of higher success rate, there were reported recurrences among different types of
SVT. The aim of this study was to report the efﬁcacy of RF ablation, its complications, recurrence
rate and its predictors.
Methods: The material of this study (our 3rd registry) included patients who underwent electro-
physiological study (EPS) and radiofrequency ablation of their supraventricular tachycardia in the
past 5 years, starting from January 2002 to January 2007 at The Critical Care Medicine Depart-
ment, Cairo University.
Results: Out of 400 pts studied, 381 (95%) had been subjected to radiofrequency ablation (RF)
ablation while the remaining 19 pts (4.7%) refused ablation for fear of possible complications. Out
of the 381 pts, 366 (96%) had their target tachycardia successfully terminated, from them 26 pts
(7%) experienced recurrence after having successful RF ablation. Nine pts (34.6%) of total recur-
rence was reported in pts with AVNRT, 7 pts (26.9%) of total recurrence was reported in pts with
AVRT utilizing septal accessory pathway (Rt AS and /or Rt PS AP), 4 pts (15.4%) was reported in
pts with double AP, 2 pts (7.7%) of total recurrence was reported in pts with AFl, one pt (3.8%) of
total recurrence was reported in cases of AT. Redo ablation have been carried out successfully in 25
pts (96.2%), and one pt (3.8%) refused ablation for fear of possible complications.hoo.com (K. Hussien).
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222 K. Hussien et al.Conclusions: Although electrophysiological study and RF ablation eliminated different types of
SVT. However, there may be increased incidence of recurrence among pts with AVNRT and AVRT
utilizing concealed septal AP and multiple APs secondary to the complexity of AVN physiology, the
critical location of septal AP, the clinical expertise, and poor electrophysiological criteria for good
procedural success.
ª 2009 King Saud University. All rights reserved.1. Introduction
Recurrences of supraventricular tachycardia (SVT) after abla-
tion have been reported to vary widely (Blomstrom-Lundqvist
et al., 2003; Clague et al., 2001; Calkins et al., 1999; Jackman
et al., 1991; Estner et al., 2005; Josephson, 2002; Charme et al.,
2003; Calkins et al., 2002; Braunwald and Zipes, 2007) and
determinants of SVT recurrence after radiofrequency are lar-
gely unknown. Several studies have analyzed whether various
clinical, electrophysiological, or procedural parameters could
be used to predict the SVT recurrence but the results have been
contradictory (Clague et al., 2001; Estner et al., 2005;
Schwacke et al., 2002; Weismuller et al., 2002).
The performance of catheter ablation procedures requires
skills that are developed over time. Several studies have shown
that success rates improve and ﬂuoroscopy times decrease with
experience (Calkins et al., 1993; Katritsis et al., 1994).
Although there are many determinants of arrhythmia recur-
rences, recurrence rates drop with operator experience (Rosen-
heck et al., 1997).
Cryoablation is emerging as an attractive treatment option
for several arrhythmia substrates in children; acute success rates
are comparable to radiofrequency ablation. But concerns sub-
sist over potentially higher recurrence rates (Kriebel et al.,
2005; Bar-Cohen et al., 2006; Papez et al., 2006). However, more
investigation is needed in order to decrease the recurrence rate
with cryoablation, since single cryoablation lesion does not seem
to lead to comparable long-term outcome to radiofrequency
ablation (RFA). The choice of larger tip cryoablation catheters
may also need to be assessed while looking for possible solution
for the long-term effectiveness (Volkan Tuzcu, 2007).
Patients with structural heart disease (SHD) and SVT who
undergo RF ablation have diverse anatomic and arrhythmia
substrates. Compared to patients with anatomically normal
hearts, they have lower acute success rate and higher recur-
rence rate. Two major subgroups predominate: Ebstein’s
anomaly and scar-related intra-atrial reentrant tachycardias
(IART) after atrial surgery. In each of these groups, the lower
acute success rates and higher recurrence rates as compared to
patients without CHD are likely due to the complex arrhyth-
mia substrate and multiple accessory pathways (Reich et al.,
1998; Triedman et al., 2002).
It was found that persistence of residual slow pathway con-
duction and single AV nodal echo beats after ablation or other
electrophysiological or procedural parameters did not predict
the risk for developing AVNRT recurrences in a large series
of patients during a long follow-up interval (Estner et al.,
2005). Younger patients being at increased risk for developing
AVNRT recurrences, (Estner et al., 2005) exact factors that pre-
dispose for AVNRT recurrence in younger patients as
compared for older patients are not known, histological and
functional studies of AV node, on the other hand, have shownage-related changes in themorphology and function ofAVnode
increasing the predisposition for AV node reentry in young
adults compared with children (Blaufox et al., 2000; Umetani
et al., 1998). Another possible explanation of increased suscep-
tibility for AVNRT recurrence in younger patients may be re-
lated to age-related changes in the underlying autonomic tone
(Bonnemeier et al., 2003; Miller and Olgin, 2002).
The probability of AVRT recurrence after a successful
ablation procedure was strongly inﬂuenced by the ablation tar-
get, with recurrence being more likely after ablation of right
free wall, posteroseptal, septal APs, and with multiple APs.
These differences in the likelihood of arrhythmia recurrence
can be explained, in large part, by the target-dependent differ-
ences in the effectiveness of tissue heating (Calkins et al., 1999;
Chen et al., 1999).
The most important feature which avoids the recurrence of
ﬂutter is the creation of a stable and complete block of isthmus
conduction (Villacastin et al., 2000; Raviele, 2005). In fact
when the validation of block was not made in the ﬁrst ‘90s
the recurrence rate of ﬂutter ablation was very high (30%) Shih
et al., 1998.
The patients with multiple atrial tachycardias also were
more likely to have recurrence. Because patient’s age and pres-
ence of structural heart diseases were the signiﬁcant predictors
of multiple atrial tachycardias, they also were the signiﬁcant
predictors of recurrence (Hussein et al., 2000).
2. Patients and methods
This retrospective-cohort study included 543 studies involving
400 patients (214 males, 186 females; their mean age was
35.7 ± 14 years) who underwent electrophysiological study(ies)
and/or radiofrequency ablation of SVT in 5-years duration
(from January 2002 to January 2007) at the Critical Care
Medicine Department, Cairo University.
All data are obtained from patients ﬁles including age, sex,
proper history analysis and structural heart disease, pre and
post catheter ECG, ECG with tachycardia if available, echo-
cardiography, electrophysiological diagnosis, results of RF
ablation, complications, and recurrence regarding predictors,
redo ablation and results.3. Electrophysiological study and radiofrequency ablation
All the studied patients underwent EPS for deﬁnitive diagnosis
of their SVT. All patients were studied in post absorptive se-
dated state. All anti-arrhythmic drugs were discontinued for
at least ﬁve half-lives. Three quadripolar catheters were in-
serted in high right atrium (HRA), atrioventricular junction
(His bundle) and right ventricular apex (RV) together with a
multipolar one in the coronary sinus (CS) for recording the left
Table 2 Recurrence rate in successfully ablated cases (26 pts).
Type of SVT Total
number of
successfully
ablated cases
Recurrence
rate among
selective SVT
Percentage
from total
recurrence
(26 pts)
AFl 31 2 (6.5%) 7.7
AT 13 1 (7.7%) 3.8
AVNRT 144 9 (6.3%) 34.6
LL AP 61 2 (3.3%) 7.7
RPS AP 26 2 (7.7%) 7.7
AS AP 26 5 (19.2%) 19.2
AVRT+ AVNRT 5 1 (20%) 3.8
LL AP + LPL AP 1 1 (100%) 3.8
AS AP +MS AP 1 1 (100%) 3.8
LL AP + AS AP 1 1 (100%) 3.8
RPS AP + LPS AP 1 1 (100%) 3.8
Table 3 Time of recurrence in successfully ablated cases.
Type of SVT Total no.
of recurrent
cases
<6 months 6 months–
2 years
>2 years
AVNRT 9 4 (44.4%) 4 (44.4%) 1 (11.1%)
AVRT 13 9 (69.2%) 2 (15.4%) 2 (15.4%)
AT 1 1 (100%) 0 (0.0%) 0 (0.0%)
AFl 2 1 (50%) 1 (50%) 0 (0.0%)
AVRT+ AVNRT 1 0 (0.0%) 1 (100%) 0 (0.0%)
Table 4 Age distribution in recurrent cases.
Type of SVT Total no.
of recur-
rent cases
Group I
(0–20)
Group II
(20–40)
Group III
above 40
years
AVNRT 9 0 (0.0%) 3 (33.3%) 6 (66.7%)
AVRT 13 8 (61.5%) 5 (38.5%) 0 (0.0%)
AT 1 0 (0.0%) 1 (100%) 0 (0.0%)
AFl 2 0 (0.0%) 0 (0.0%) 2 (100%)
AVRT+ AVNRT 1 0 (0.0%) 1 (100%) 0 (0.0%)
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catheter (Cordis-webster), 20 poles, 2 mm paired spacing was
inserted in place of HRA catheter for detailed mapping of
anterolateral RA wall and lateral part of the inferior vena
cava–tricuspid isthmus (IVC–TA). The recording was made
on a computerized multi-channel recorder (BARD medical
system).
Electrical stimulation was delivered through a programma-
ble stimulator (‘‘Nihon Kohden’’ Japan).
The electrophysiological study consisted of: Analysis of
intracardiac electrograms.
 Antegrade curve i.e. (atrial pacing with atrial extrastimulus)
to determine atrial, AV nodal refractory periods and
evidence of dual AV nodal pathways.
 Retrograde curve i.e. (ventricular pacing with ventricular
extrastilmulus) to determine His bundle retrograde refrac-
tory period and to conﬁrm or exclude retrograde conduc-
tion via an accessory pathway.
 Induction of SVT by atrial and/or ventricular
extrastimulation.
 Incremental pacing (atrial and ventricular) to detect ante-
grade and retrograde Wenckbach respectively.
 If all failed to induce tachycardia, isoprenaline (at graded
doses, 1–4 mcg/min) or atropine (0.04 mg/kg) was given
intravenously.
Conventional RF ablation was performed with a generator
(‘‘Stockert, ep shuttle’’ Biosense, Webster) connected to
mapping ablation catheter 4 mm tip (Cordis-Webster). Other
mapping/ablation catheters were used namely; Stinger, Bard,
Blazer and EPT.
Three dimensional mapping system (CARTO XP – Bio-
sense) connected to mapping/ablation 8 mm tip catheter (Nav-
istar) was used for redo ablation of few recurrent difﬁcult cases.
4. Statistical methods
Descriptive analysis for quantitative and qualitative data
respectively in the form of (mean ± SD and percentage).
5. Results
5.1. Patients, characteristics
Twenty six patient (7.1%) with successful RF ablation of their
SVTof total 366 pts experienced recurrence of their tachycardia.
Structural heart diseases were reported in 2 pts with
AVNRT and systemic diseases were reported in 3 pts (2 with
AVNRT and 1 with atrial ﬂutter1 (AFl)) – Table 1.Table 1 Structural heart diseases and systemic diseases in
recurrent cases.
Type of SVT No. SHD Systemic disease
AVRT 4 VSD in 1
LVH in 1
T2DM+HTN in 1
Hypothyroidism in 1
AFl 1 – HTN+ chronic liver disease
T2DM: type 2 diabetes mellitus; HTH: hypertension.
VSD: ventricular septal defect; LVH: LV hypertrophy.Nine pts (34.6%) of 26 who had recurrence were reported in
pts with AVNRT, 5 (19.2%) was reported in pts with antero-
septal AP, and 2 (7.7%) was reported in pts with right postero-
septal AP, left lateral AP, and AFl Table 2.
5.1.1. Time of recurrence
Out of 26 pts, 15 (57.7%) had recurrence before 6 months, 8 pts
(30.8%) had recurrence between 6 months and 2 years, and 3
pts (11.5%) had it more than 2 years respectively Table 3.Table 5 Sex distribution in recurrent cases of SVT.
Type of SVT Total no. of
recurrent cases
Male Female
AVNRT 9 5 (55.6%) 4 (44.4%)
AVRT 13 9 (69.2%) 4 (30.8%)
AT 1 0 (0.0%) 1 (100%)
AFl 2 2 (100%) 0 (0.0%)
AVRT+ AVNRT 1 0 (100%) 1 (100%)
Fig. 1 (a) 12-Lead ECG with counterclockwise ﬂutter. (b) Intracardiac recording conﬁrming early activation of the proximal Halo 9,10
during AFl with counterclockwise rotation. (c) Successful RF ablation of cavo–tricuspid ismuth with termination of AFl. (d) Validation of
isthmus block: the distal Halo1,2 is activated later during PCS pacing. (e) Failed post ablation induction by IAP. (f) Post-ablation ECG in
SR. (g) Standard AP view. Activation mapping during AFl in the same pt with early recurrence by 3-D electro-anatomic mapping system
(CARTO). (h) LAO view activation mapping during AFl with counterclockwise rotation (early activation in red and late activation in
violet). (i) Linear RF ablation of the cavo–tricuspid isthmus (tagged with red) with ﬂutter termination. (j) Block validation during PCS
pacing in inferior view. (k) Block validation was conﬁrmed also in LAO view.
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Fig. 1 (continued)
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226 K. Hussien et al.5.1.2. Age distribution in recurrent cases
The age has been classiﬁed into three age groups:
 Group I: <20 years
 Group II: between 20 and 40 years
 Group III: >40 years Out 26 pts, 10 (38.4%) were in age group II (20–40), 8
(30.8%) were in age group I (0–20) as were as age group
III (>40 years), Table 4. All cases in age group I (0–20) (30.8%) were diagnosed as
having AVRT.
 All atrial ﬂutter cases (2 pts) were in age group III
(>40 years).5.1.3. Gender distribution in recurrent cases
Out of 26 pts, 16 (61.6%) were males, 10 (38.4%) were females
Table 5.
 Out of 26 pts with recurrent SVT, 6 (23.1%) had different
EP diagnosis in the second study.
Table 6 Comparison of results of atrial ﬂutter ablation in
different series.
Author Year No. of
pts
Success
rate (%)
Recurrence
No. %
Chen et al. 1994 18 94 5/18 94
Steinberg et al. 1995 16 100 4/16 100
Poty et al. 1995 12 100 1/12 100
Poty et al. 1996 44 98 4/43 98
Willems et al. 1999 24 100 2/24 100
Hussein et al.,
Magdi et al. (2004)
2000 44 86.4 2/38 86.4
Magdy et al.,
Hussein et al. (2004)
2002 10 80 3/8 80
Present study 2007 34 91.2 2/31 91.2
Table 7 Comparison of results of atrial tachycardia ablation
in different series.
Author Year No. of pts Success
rate (%)
Recurrence
Poty et al. 1996 36 86 –
Shaban et al. 1997 11 81 –
Kalman et al. 1998 27 96 –
Hussein et al. 2000 9 66 2/6 (33%)
Magdy et al. 2002 30 70 2/21 (13%)
Present study 2007 16 81.3 1/13 (7.7%)
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pts (80.8%) were ablated in the 2nd study, 3 (11.5%) were
ablated in the 3rd study respectively. The other 2 pts
(7.7%), one refused ablation for fear of complications, the
other one had failed ablation in the 2nd study and contin-
ued the anti-arrhythmic drugs (He was diagnosed as having
AVRT with AS AP).
 Two pts (7.7%) out of 26 who had experienced recurrence,
were not completely ablated in the 1st study for fear of epi-
cardial location of their accessory pathways but was com-
pletely ablated in the 2nd study.
 Two pts who had AVRT (1 with left PL location and the
other one with left PS location) had their accessory path-
ways reablated successfully using irrigated tip (8 mm) cath-
eter (Navistar-thermo cool).
 One pt with AFl who experienced recurrence after success-
ful conventional linear ablation of IVC–tricuspid isthmus
had second successful attempt using 3-D mapping system
(CARTO XP) connected to 8 mm tip thermo dilution cath-
eter – Fig. 1.
6. Discussion
The results of this retrospective-cohort study (our 2nd pub-
lished registry) from the Critical Care Center at Cairo Univer-
sity Hospitals 34 and the prior studies indicate that RF
catheter ablation can be done with a high success rate and
low incidence of complications. In this study, the reported
acute success rate was high (96.1%), the recurrence rate was
low (7.1%), and the incidence of complications was relatively
low (4.2%).The study also identiﬁed some types of SVT that are predic-
tive of ablation success as AVNRT (99.3%), left lateral AP
(100%), right posteroseptal (100%) and anteroseptal AP
(96.3%). It also identiﬁed some types of SVT that are predic-
tive of ablation failure as, atrial tachycardia (18.75%). It also
identiﬁed the clinical variables that predict development of
arrhythmia recurrences and complications as structural heart
disease, multiple ablation targets, septal AP, and AVNRT.
The recurrence rate in our series was 7.1%, the highest rate
of recurrence in multiple APs (50%) followed by anteroseptal
AP (19.2%), atrial tachycardia and right posteroseptal AP
(7.7%), then AFl 6.5%. The lowest rate of recurrence was re-
ported in AVNRT (6.3%).
Calkins et al. (1999) found that total recurrence in SVT
was 6% (47 pts); where 31 pts (7.8%) who had RF ablation
for an AP, and 16 pts (4.6%) who had RF ablation of
AVNRT. The study did not show the recurrence rate in differ-
ent individual types of APs.
The recurrence rates in atrial ﬂutter and atrial tachycardia
were previously shown in Tables 6 and 7 respectively. The
higher recurrence rates (in the previous study in comparison
to our study) in atrial ﬂutter and atrial tachycardia cases
may reﬂect the difference in experience, in technique used dur-
ing mapping and ablation, and the small sample size (limited
number of patients). Introducing the 3-D mapping/ablation
system (CARTO) in our center has revolutionized manage-
ment of do novo cases of AT and atypical atrial ﬂutter with
higher success rate and lower incidence of recurrence. At pres-
ent, Conventional mapping/ablation technique has never used
for cases of AT.
Recurrence occurred in 57.7% before 6 months and in
89.5% before 2 years. It was up to 90% before 6 months as re-
ported in Calkins series, (Calkins et al., 1999) and in Van Hare
series (Van Hare et al., 2004).
Thirty eight percent of recurrent cases were reported in
middle age group, of which, 30.8% were in young and in old
age group. In AVNRT there were no recurrent cases in young
age group in contradictory to Estner series where recurrence
rate was higher in young age group. The difference may be
due to small sample size.
7. The limitations of the study
1. It was a retrospective study lacking follow-up and detec-
tion of echocardiographic changes following the catheter
ablations as valvular damage, pericardial effusion and
recently developed RWMAs which might occur without
detection.
2. Some intra-cath procedures were not properly assessed as
the procedure time, number of RF pulses, and the exposure
time.8. Conclusion
There is increased incidence of recurrence among pts with
AVNRT and AVRT utilizing concealed septal AP and multi-
ple APs secondary to the complexity of AV nodal physiology,
the critical location of septal AP and poorly deﬁned electro-
physiological criteria for procedural success.
Identiﬁcation of groups of patients with higher rates of
recurrence after catheter ablation will stimulate further
228 K. Hussien et al.investigations of the potential predictors of recurrence and
how to decrease it.
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